series-c-plus
Stage
1
Investors
About
Encoded Therapeutics develops precision genetic medicines using a novel targeting and regulation platform to create gene therapies for neurological disorders, including programs for Dravet Syndrome.
Explore Encoded Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.